| Product Code: ETC7630617 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Gadolinium-based Contrast Media Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Gadolinium-based Contrast Media Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Gadolinium-based Contrast Media Market - Industry Life Cycle |
3.4 Ireland Gadolinium-based Contrast Media Market - Porter's Five Forces |
3.5 Ireland Gadolinium-based Contrast Media Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Ireland Gadolinium-based Contrast Media Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.7 Ireland Gadolinium-based Contrast Media Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Ireland Gadolinium-based Contrast Media Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as cancer and cardiovascular diseases, leading to a higher demand for diagnostic imaging procedures using gadolinium-based contrast media. |
4.2.2 Technological advancements in imaging techniques and contrast agents, enhancing the effectiveness and accuracy of diagnostic procedures. |
4.2.3 Growing investments in healthcare infrastructure and facilities in Ireland, improving access to advanced medical imaging services. |
4.3 Market Restraints |
4.3.1 Regulatory challenges and safety concerns regarding the use of gadolinium-based contrast media, leading to potential restrictions or limitations on their usage. |
4.3.2 Competition from alternative imaging modalities and contrast agents, impacting the market share of gadolinium-based contrast media. |
4.3.3 Economic fluctuations and budget constraints in the healthcare sector, affecting the affordability and adoption of expensive contrast media products. |
5 Ireland Gadolinium-based Contrast Media Market Trends |
6 Ireland Gadolinium-based Contrast Media Market, By Types |
6.1 Ireland Gadolinium-based Contrast Media Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Gadolinium-based Contrast Media Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Ireland Gadolinium-based Contrast Media Market Revenues & Volume, By Extracellular agents, 2021- 2031F |
6.1.4 Ireland Gadolinium-based Contrast Media Market Revenues & Volume, By Blood pool agents, 2021- 2031F |
6.1.5 Ireland Gadolinium-based Contrast Media Market Revenues & Volume, By Hepatobiliary agents, 2021- 2031F |
6.2 Ireland Gadolinium-based Contrast Media Market, By Modality |
6.2.1 Overview and Analysis |
6.2.2 Ireland Gadolinium-based Contrast Media Market Revenues & Volume, By MRI, 2021- 2031F |
6.2.3 Ireland Gadolinium-based Contrast Media Market Revenues & Volume, By MRA, 2021- 2031F |
6.3 Ireland Gadolinium-based Contrast Media Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Ireland Gadolinium-based Contrast Media Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.3.3 Ireland Gadolinium-based Contrast Media Market Revenues & Volume, By Neurology, 2021- 2031F |
6.3.4 Ireland Gadolinium-based Contrast Media Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.5 Ireland Gadolinium-based Contrast Media Market Revenues & Volume, By Others (Musculoskeletal), 2021- 2031F |
7 Ireland Gadolinium-based Contrast Media Market Import-Export Trade Statistics |
7.1 Ireland Gadolinium-based Contrast Media Market Export to Major Countries |
7.2 Ireland Gadolinium-based Contrast Media Market Imports from Major Countries |
8 Ireland Gadolinium-based Contrast Media Market Key Performance Indicators |
8.1 Patient satisfaction scores related to diagnostic imaging procedures involving gadolinium-based contrast media. |
8.2 Utilization rates of advanced imaging technologies in healthcare facilities. |
8.3 Adoption rates of new gadolinium-based contrast media formulations or products in the market. |
8.4 Research and development investments in improving the safety profile and efficacy of gadolinium-based contrast media. |
8.5 Number of healthcare facilities offering diagnostic imaging services using gadolinium-based contrast media. |
9 Ireland Gadolinium-based Contrast Media Market - Opportunity Assessment |
9.1 Ireland Gadolinium-based Contrast Media Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Ireland Gadolinium-based Contrast Media Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.3 Ireland Gadolinium-based Contrast Media Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Ireland Gadolinium-based Contrast Media Market - Competitive Landscape |
10.1 Ireland Gadolinium-based Contrast Media Market Revenue Share, By Companies, 2024 |
10.2 Ireland Gadolinium-based Contrast Media Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |